An investor in NYSE:GM shares filed a lawsuit over alleged Securities Laws violations by General Motors in connection. Investors who purchased shares of General Motors Company (NYSE:GM) should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 – 1554. The plaintiff claims that between February 27, 2012 and May 25, 2017 the defendants made […]
NYSE:DKS Investor News: Lawsuit filed against Dicks Sporting Goods Inc
An investor in NYSE:DKS shares filed a lawsuit over alleged violations of Federal Securities Laws by Dicks Sporting Goods Inc. Investors who purchased shares of Dicks Sporting Goods Inc (NYSE:DKS) should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 – 1554. The plaintiff claims that between March 7, 2017 and May 15, 2017, […]
NYSE:SNAP Investor News: Lawsuit filed against Snap Inc
An investor in NYSE:SNAP shares filed a lawsuit in over alleged violations of Federal Securities Laws by Snap Inc. Investors who purchased shares of Snap Inc (NYSE:SNAP) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 – 1554. The plaintiff alleges on behalf of investors, who purchased Snap Inc […]
NYSE:PBYI Investor News: Lawsuit filed against Puma Biotechnology Inc
An investor in NYSE:PBYI shares filed a lawsuit over alleged violations of Federal Securities Laws by Puma Biotechnology Inc. Investors who purchased shares of Puma Biotechnology Inc (NYSE:PBYI) should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 – 1554. The plaintiff claims that between February 29, 2016 and May 4, 2017, the Defendants […]
NASDAQ:NTRP Investor News: Lawsuit filed against Neurotrope Inc
An investor in NASDAQ:NTRP shares filed a lawsuit over alleged violations of Federal Securities Laws by Neurotrope Inc. Investors who purchased shares of Neurotrope Inc (NASDAQ:NTRP) should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 – 1554. The plaintiff claims that between January 7, 2016, and April 28, 2017 Neurotrope issued materially false […]
NASDAQ:ITCI Investor News: Lawsuit filed against Intra-Cellular Therapies Inc
An investor in NASDAQ:ITCI shares filed a lawsuit over alleged violations of Federal Securities Laws by Intra-Cellular Therapies Inc. Investors who purchased shares of Intra-Cellular Therapies Inc (NASDAQ:ITCI) should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 – 1554. The plaintiff claims that between August 12, 2014 through April 28, 2017, the defendants […]
- 1
- 2
- 3
- …
- 282
- Next Page »